Science and Medicine Group

Instrument Business Outlook Volume 33 - Issue 7 16 Jul 2024

Report details
6 Figures
16 Tables

R&D Spending Shows Little Increases in FY23
- R&D Spending Changes
- R&D vs. Sales Changes
- R&D as a Percentage of Sales
- Foreign Companies
- Conclusion
Executive Briefing
- Illumina Makes scRNA-Seq-related Acquisition
- Malvern Panalytical Enters New Markets
- Thermo Fisher Closes Olink Transaction
- Certara Buys Cheminformatics Firm
- Spanish Distributor Acquired
- Indian Firm Lists on Stock Exchanges
First Quarter Results: 10x Genomics, Biotage, HORIBA and Pacific Biosciences
- 10x Genomics Posts Mixed Results for First Quarter
- Biotage Sales Helped by Acquisitions
- HORIBA’s Sales Performance in Asia Drives Sales
- Pacific Biosciences Records Sales Headwinds in China
Market Profile: Precast Electrophoresis Gels
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: R&D Spending to Slow in 2024
- Government: Courts Gain New Regulatory Authority
- Clinical: Medical Lab Survey Shows Common KPIs
Region Watch
- Europe: Pharma R&D Grows in 2023
- UK: Life Science Indicators Released
- Sri Lanka: Scientific Institutes Survey
News
- Broad-Based Companies
  - Company Announcements
- Life Science Instruments
  - Company Announcements
  - Product Introductions
  - Gene-Based Analysis
  - Company Announcements
  - Production Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- MS, LC-MS & GC-MS
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Laboratory Products
  - Laboratory Automation
  - Company Announcements
  - Product Introduction
  - Laboratory Equipment
  - Company Announcements
  - Product Introductions
  - Consumables
  - Company Announcements
  - Electrochemistry
  - Product Introduction
Bottom Line

Attachments

IBO 071624 Issue.pdf

Instrument Business Outlook Volume 33 - Issue 7

16 Jul 2024

Request Access

Table of Contents

R&D Spending Shows Little Increases in FY23
- R&D Spending Changes
- R&D vs. Sales Changes
- R&D as a Percentage of Sales
- Foreign Companies
- Conclusion
Executive Briefing
- Illumina Makes scRNA-Seq-related Acquisition
- Malvern Panalytical Enters New Markets
- Thermo Fisher Closes Olink Transaction
- Certara Buys Cheminformatics Firm
- Spanish Distributor Acquired
- Indian Firm Lists on Stock Exchanges
First Quarter Results: 10x Genomics, Biotage, HORIBA and Pacific Biosciences
- 10x Genomics Posts Mixed Results for First Quarter
- Biotage Sales Helped by Acquisitions
- HORIBA’s Sales Performance in Asia Drives Sales
- Pacific Biosciences Records Sales Headwinds in China
Market Profile: Precast Electrophoresis Gels
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: R&D Spending to Slow in 2024
- Government: Courts Gain New Regulatory Authority
- Clinical: Medical Lab Survey Shows Common KPIs
Region Watch
- Europe: Pharma R&D Grows in 2023
- UK: Life Science Indicators Released
- Sri Lanka: Scientific Institutes Survey
News
- Broad-Based Companies
  - Company Announcements
- Life Science Instruments
  - Company Announcements
  - Product Introductions
  - Gene-Based Analysis
  - Company Announcements
  - Production Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- MS, LC-MS & GC-MS
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Laboratory Products
  - Laboratory Automation
  - Company Announcements
  - Product Introduction
  - Laboratory Equipment
  - Company Announcements
  - Product Introductions
  - Consumables
  - Company Announcements
  - Electrochemistry
  - Product Introduction
Bottom Line